- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PhaseBio Pharmaceuticals Inc (PHAS)
NASDAQ
Currency in USD
0.070
-0.025(-26.21%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.067
0.092
52 wk Range
0.067
0.092
PHAS Cash Flow Statement
Featured here, the Cash Flow Statement for PhaseBio Pharmaceuticals Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).
Advanced Cash Flow Statement
Collapse All
| Period Ending: | 2016 31/12 | 2017 31/12 | 2018 31/12 | 2019 31/12 | 2020 31/12 | 2021 31/12 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -47.42 | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||
Cash from Investing | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -2.68 | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||
Cash from Financing | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 63.77 | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||
Net Change in Cash | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 13.68 | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||
* In Millions of USD (except for per share items)
